Transgenic mice overproducing islet amyloid polypeptide have increased insulin storage and secretion in vitro |
| |
Authors: | C. B. Verchere D. A. D'Alessio R. D. Palmiter S. E. Kahn |
| |
Affiliation: | (1) Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, USA;(2) Veterans Affairs Medical Center, Seattle, Washington, USA;(3) Howard Hughes Medical Institute, University of Washington, Seattle, Washington, USA |
| |
Abstract: | Summary To determine whether chronic overproduction of islet amyloid polypeptide alters beta-cell function, we studied a line of transgenic mice which overexpress islet amyloid polypeptide in their beta-cells. At 3 months of age, these transgenic mice had greater pancreatic content of both islet amyloid polypeptide and insulin. Further, basal and glucose-stimulated secretion of both islet amyloid polypeptide and insulin were also elevated in the perfused pancreas of the transgenic animals. These findings demonstrate that chronic overproduction and secretion of islet amyloid polypeptide are associated with increased insulin storage and enhanced secretion of insulin in vitro. This increase in insulin storage and secretion may be due to a direct effect of islet amyloid polypeptide on the beta-cell or a betacell adaptation to islet amyloid polypeptide-induced insulin resistance.Abbreviations IAPP Islet amyloid polypeptide - bp base pair - TFA trifluoroacetic acid - IRI immunoreactive insulin - SLI somatostatin-like immunoreactivity - IAPP-LI IAPP-like immunoreactivity |
| |
Keywords: | Insulin islet amyloid polypeptide pancreas secretion |
本文献已被 SpringerLink 等数据库收录! |
|